Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Circulating insulin-like growth factor-1 and risk of total and 19 site-specific cancers: cohort study analyses from the UK Biobank
F 1.8,7.2 = 38.24, p = 0.0002 using Baseline control
The present real-world study was unable to do a subgroup analysis due to insufficient participation
Study procedure (Koide et al., 2025) GLP-1RA therapy significantly reduced blood glucose levels, body weight, and body fat percentage Results showed that after 12 months of treatment, GLP-1RA therapy significantly reduced participants blood glucose levels (as measured by glycated hemoglobin), body weight, and body fat percentage
US$ 26.34
US$ 25.35
US$ 26.32
US$ 25.05
